Financhill
Back

Sturm Ruger & Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
45

RGR
Sturm Ruger &

Last Price:
41.71
Seasonality Move:
-4.05%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
45
Sturm Ruger & (RGR) is a Sell

Is Sturm Ruger & a Buy, Sell or Hold?

  • The current Sturm Ruger & [RGR] share price is $41.71. The Score for RGR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • RGR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RGR Stock Price Chart

What is Sturm Ruger &'s stock price today?

  • The Sturm Ruger & share price today is $41.71
    The current trend is relatively stagnant and RGR is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 50.28 Buy
Chaikin Money Flow: -635863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.11 - 42.15) Buy
Bollinger Bands (100): (41.16 - 44.22) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

RGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.46 Buy
20-day SMA: 41.54 Buy
50-day SMA: 42.36 Sell
200-day SMA: 43.71 Sell
8-day EMA: 41.59 Buy
20-day EMA: 41.59 Buy
50-day EMA: 42.02 Sell
200-day EMA: 44.38 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Sturm Ruger & Earnings Growth & RGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.53 per share, and an increase next year of $0.60 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Sturm Ruger & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):